140 related articles for article (PubMed ID: 24640466)
1. Credible deterrence: FDA and the Park Doctrine in the 21st century.
O'Leary P
Food Drug Law J; 2013; 68(2):137-88, i. PubMed ID: 24640466
[TBL] [Abstract][Full Text] [Related]
2. Onus of responsibility: the changing responsible corporate officer doctrine.
Bragg J; Bentivoglio J; Collins A
Food Drug Law J; 2010; 65(3):525-38, ii-iii. PubMed ID: 24479239
[TBL] [Abstract][Full Text] [Related]
3. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
4. Holding Pharmaceutical and Medical Device Executives Accountable as Responsible Corporate Officers.
Daval CJR; Avorn J; Kesselheim AS
JAMA Intern Med; 2022 Nov; 182(11):1199-1205. PubMed ID: 36121676
[TBL] [Abstract][Full Text] [Related]
5. Civil and criminal liability associated with food recalls.
Packman JM
Food Drug Law J; 1998; 53(3):437-52. PubMed ID: 10346721
[No Abstract] [Full Text] [Related]
6. Pharmaceutical industry wins "round one" in protections against product liability claims.
Gatty B
Hosp Formul; 1995 Apr; 30(4):238, 237. PubMed ID: 10141868
[No Abstract] [Full Text] [Related]
7. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
Struve CT
Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
[No Abstract] [Full Text] [Related]
8. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
Green W
Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
[No Abstract] [Full Text] [Related]
9. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion.
Surprenant JA
Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554
[TBL] [Abstract][Full Text] [Related]
10. Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.
Nguyen D; Seoane-Vazquez E; Rodriguez-Monguio R; Montagne M
BMC Health Serv Res; 2013 Jan; 13():27. PubMed ID: 23339419
[TBL] [Abstract][Full Text] [Related]
11. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.
Smirniotopoulos A
Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960
[TBL] [Abstract][Full Text] [Related]
12. Corporate compliance programs for FDA-regulated companies: incentives for their development and the impact of the federal sentencing guidelines for organizations.
Freyer DH
Food Drug Law J; 1996; 51(2):225-42. PubMed ID: 11820200
[No Abstract] [Full Text] [Related]
13. Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs.
O'Reilly J; Dalal A
Ann Health Law; 2003; 12(2):295-324, table of contents. PubMed ID: 12856461
[TBL] [Abstract][Full Text] [Related]
14. Correcting the record: Australian prosecutions for manslaughter in the medical context.
Carter DJ
J Law Med; 2015 Mar; 22(3):588-609. PubMed ID: 25980192
[TBL] [Abstract][Full Text] [Related]
15. United States v. Levin: entrapment by estoppel doctrine applied in Medicare reimbursement context.
Shaw PW; Griffith RA
Med Staff Couns; 1993; 7(4):55-8. PubMed ID: 10183936
[TBL] [Abstract][Full Text] [Related]
16. The HEALTH Act's FDA defense to punitive damages: a gift to drug makers or to the public?
Levy E
Fordham Law Rev; 2006 Mar; 74(4):2425-60. PubMed ID: 17115481
[No Abstract] [Full Text] [Related]
17. A legal assessment of FDA's new HACCP regulations.
McNamara SH
Food Drug Law J; 1997; 52(1):39-47. PubMed ID: 10346708
[No Abstract] [Full Text] [Related]
18. Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.
Rostron A
Duke Law J; 2011 Feb; 60(5):1123-91. PubMed ID: 21365961
[TBL] [Abstract][Full Text] [Related]
19. Legal responsibilities of the pathologist.
Picut CA; Parker GA
Toxicol Pathol; 1994; 22(2):213-21. PubMed ID: 7973371
[TBL] [Abstract][Full Text] [Related]
20. The Supreme Court, preemption, and malpractice liability.
Kesselheim AS; Studdert DM
N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
